The objective of the Cardiovascular Pharmacology research group is to identify molecular key signals for cardiovascular diseases. The work focuses, among other things, on cardiac insufficiency and cardiac hypertrophy.
The research group ERC-Sulfaging investigates the connection between ageing processes and so-called gasotransmitter signalling.
The Miniaturisation group specialises in developing and characterising miniaturised plasmas for analytical chemistry.
The Preclinical Metabolomics research group uses technologies developed at ISAS to investigate metabolic heterogeneity in tumors and their metastases.